美国 · SEC FORM 4
Rein Therapeutics, Inc.
RNTX · Nasdaq · CIK 0001420565 · Healthcare · Biotechnology
内部人信号
2 位买方 · 5 条买入交易行 · $74.7K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Purchase activity is becoming less recent
- ✓ 角色得分高 · 买入者中职位最高的是：Director
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: See Remarks. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 51.6
- 51.6
- 51.5
- 51.5
- 51.4
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +1.7%
- 3M
- -12.6%
- 6M
- -46.7%
- 12M
- -42.9%
波动率与流动性
- 波动率
- 91.2%
- Beta
- —
- 平均每日成交额
- USD 341,377
估值
- 市值
- USD 68.5M
- P/E
- —
基本面
- 利润率
- —
- ROE
- -295.0%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-12 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 651,179
- 上期报告
- 670,748
- 日均成交量
- 277,566
- 回补天数
- 2.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 4,500 | USD 1.07 | USD 4,815 | SEC 申报 ↗ |
| 2026-05-26 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 23,190 | USD 1.06 | USD 24,581 | SEC 申报 ↗ |
| 2026-05-22 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 15,950 | USD 1.05 | USD 16,748 | SEC 申报 ↗ |
| 2026-05-21 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 3,420 | USD 1.04 | USD 3,557 | SEC 申报 ↗ |
| 2026-04-30 | WINDSOR JAMES BRIAN | 买入 (P) | Common stock , $0.001 par value | 25,000 | USD 1.00 | USD 25,000 | SEC 申报 ↗ |
| 2025-11-14 | Cocke Travis W.; Voss Advisors GP, LLC; Voss Capital, LP; Voss Value Master Fund, LP; Voss Value-Oriented Special Situations Fund, LP | 买入 (P) | Common Stock, $0.001 par value | 104,183 | USD 1.22 | USD 127,103 | SEC 申报 ↗ |
| 2025-10-28 | Cocke Travis W.; Voss Advisors GP, LLC; Voss Capital, LP; Voss Value Master Fund, LP; Voss Value-Oriented Special Situations Fund, LP | 买入 (P) | Common Stock, $0.001 par value | 178,392 | USD 1.39 | USD 247,965 | SEC 申报 ↗ |
| 2025-10-27 | Cocke Travis W.; Voss Advisors GP, LLC; Voss Capital, LP; Voss Value Master Fund, LP; Voss Value-Oriented Special Situations Fund, LP | 买入 (P) | Common Stock, $0.001 par value | 97,482 | USD 1.37 | USD 133,550 | SEC 申报 ↗ |
| 2025-10-24 | Cocke Travis W.; Voss Advisors GP, LLC; Voss Capital, LP; Voss Value Master Fund, LP; Voss Value-Oriented Special Situations Fund, LP | 买入 (P) | Common Stock, $0.001 par value | 30,176 | USD 1.39 | USD 41,945 | SEC 申报 ↗ |
| 2024-12-05 | WINDSOR JAMES BRIAN | 买入 (P) | Common Stock | 400 | USD 2.24 | USD 898 | SEC 申报 ↗ |
| 2023-12-15 | WINDSOR JAMES BRIAN | 买入 (P) | Common Stock | 225 | USD 3.37 | USD 758 | SEC 申报 ↗ |
| 2023-11-20 | WINDSOR JAMES BRIAN | 买入 (P) | Common Stock | 5,076 | USD 1.97 | USD 10,000 | SEC 申报 ↗ |
| 2021-01-08 | Satter Muneer A | 买入 (P) | Common Stock | 9,000,000 | USD 1.10 | USD 9,900,000 | SEC 申报 ↗ |
| 2020-06-15 | Ambros Reinhard J. | 买入 (P) | Common Stock | 5,800 | USD 1.22 | USD 7,076 | SEC 申报 ↗ |
| 2020-06-08 | VON RICKENBACH JOSEF H | 买入 (P) | Common Stock | 227,272 | USD 1.10 | USD 249,999 | SEC 申报 ↗ |
Form 4 申报证据
10 transaction lines in the latest 365-day window; 71 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 4,500 | USD 1.07 | USD 4,815 | SEC 申报 ↗ |
| 2026-05-26 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 23,190 | USD 1.06 | USD 24,581 | SEC 申报 ↗ |
| 2026-05-22 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 15,950 | USD 1.05 | USD 16,748 | SEC 申报 ↗ |
展开近期 Form 4 证据 (9 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 4,500 | USD 1.07 | USD 4,815 | SEC 申报 ↗ |
| 2026-05-26 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 23,190 | USD 1.06 | USD 24,581 | SEC 申报 ↗ |
| 2026-05-22 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 15,950 | USD 1.05 | USD 16,748 | SEC 申报 ↗ |
| 2026-05-21 | VON RICKENBACH JOSEF H | 买入 (P) | Common stock , $0.001 par value | 3,420 | USD 1.04 | USD 3,557 | SEC 申报 ↗ |
| 2026-04-30 | WINDSOR JAMES BRIAN | 买入 (P) | Common stock , $0.001 par value | 25,000 | USD 1.00 | USD 25,000 | SEC 申报 ↗ |
| 2025-11-14 | Cocke Travis W.; Voss Advisors GP, LLC; Voss Capital, LP; Voss Value Master Fund, LP; Voss Value-Oriented Special Situations Fund, LP | 买入 (P) | Common Stock, $0.001 par value | 104,183 | USD 1.22 | USD 127,103 | SEC 申报 ↗ |
| 2025-10-28 | Cocke Travis W.; Voss Advisors GP, LLC; Voss Capital, LP; Voss Value Master Fund, LP; Voss Value-Oriented Special Situations Fund, LP | 买入 (P) | Common Stock, $0.001 par value | 178,392 | USD 1.39 | USD 247,965 | SEC 申报 ↗ |
| 2025-10-27 | Cocke Travis W.; Voss Advisors GP, LLC; Voss Capital, LP; Voss Value Master Fund, LP; Voss Value-Oriented Special Situations Fund, LP | 买入 (P) | Common Stock, $0.001 par value | 97,482 | USD 1.37 | USD 133,550 | SEC 申报 ↗ |
| 2025-10-24 | Cocke Travis W.; Voss Advisors GP, LLC; Voss Capital, LP; Voss Value Master Fund, LP; Voss Value-Oriented Special Situations Fund, LP | 买入 (P) | Common Stock, $0.001 par value | 30,176 | USD 1.39 | USD 41,945 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RNTX |
| CIK | 0001420565 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 71 transaction lines from 2020-06-08 to 2026-05-27 18 P purchase lines · 52 S sale lines · 1 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.